SLC31A1 expression is increased in cervical cancer, endometrial cancer (EC) and breast cancer (BC), but decreased in clear cell renal cell carcinoma (ccRCC), hepatocellular carcinoma (HCC) and lung adenocarcinoma (LUAD). Here, SLC31A1 is linked to hepatocellular carcinoma.